Asunto(s)
Medicina de las Adicciones , Reducción del Daño , Medicina de las Adicciones/legislación & jurisprudencia , Medicina de las Adicciones/métodos , Medicina de las Adicciones/organización & administración , Medicina de las Adicciones/tendencias , Reducción del Daño/fisiología , Política de Salud , Humanos , Medicina Preventiva/legislación & jurisprudencia , Medicina Preventiva/métodos , Medicina Preventiva/organización & administración , Medicina Preventiva/tendencias , Conducta de Reducción del RiesgoRESUMEN
Mexico has experienced disproportionate drug-related harms given its role as a production and transit zone for illegal drugs destined primarily for the USA. In response, in 2009, the Mexican federal government passed legislation mandating pre-arrest diversion of drug-dependent individuals towards addiction treatment. However, this federal law was not specific about how the scale-up of the addiction treatment sector was to be operationalised. We therefore conducted in-depth qualitative interviews with key 'interactors' in fields affected by the federal legislation, including participants from the law enforcement, public health, addiction treatment, and governmental administration sectors. Among 19 participants from the municipal, state and federal levels were interviewed and multiple barriers to policy reform were identified. First, there is a lack of institutional expertise to implement the reform. Second, the operationalisation of the reform was not accompanied by a coordinated action plan. Third, the law is an unfunded mandate. Institutional barriers are likely hampering the implementation of Mexico's policy reform. Addressing the concerns expressed by interactors through the scale-up of services, the provision of increased training and education programmes for stakeholders and a coordinated action plan to operationalise the policy reform are likely needed to improve the policy reform process.
Asunto(s)
Medicina de las Adicciones/legislación & jurisprudencia , Reforma de la Atención de Salud , Accesibilidad a los Servicios de Salud , Formulación de Políticas , Trastornos Relacionados con Sustancias/tratamiento farmacológico , Femenino , Humanos , Entrevistas como Asunto , Masculino , México , Salud Pública , Investigación CualitativaRESUMEN
The intent of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 is to eliminate differences between health insurance coverage of mental health and substance use disorder benefits and coverage of medical or surgical benefits. The Affordable Care Act significantly extended the reach of the Wellstone-Domenici law by applying it to new insurance markets. We summarize the evolution of legislative and regulatory actions to bring about federal insurance parity. We also summarize available evidence on how the Wellstone-Domenici law has contributed to addressing insurance discrimination; rectifying market inefficiencies due to adverse selection; and altering utilization, spending, and health outcomes for people with mental health and substance use disorders. In addition, we highlight important gaps in knowledge about how parity has been implemented, describe the groups still lacking parity-level coverage, and make recommendations on steps to improve the likelihood that the Wellstone-Domenici law will fulfill the aims of its architects.